Private limited company · founded 2025 · active for 1 yearBoomgaardstraat 11, 8870 Izegem, BelgiumKBO/BCE: BE 1028.294.624
Summary
Hematologie Ieper has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,000. Its solvency ranks better than 14% of 2,800 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
ChiLi & CoDirector · permanent representative Chiel Gharakhani
2025 accounts 5 days early
Signalsraises riskEquity €1,000 (1.1% of total assets)Weak solvency vs sectorYoung companylowers riskSector: Office administrative, office support and other business support activities (NACE 82)Liquidity: current ratio 0.88, cash €15,267Size: total assets €89,001neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
No current score
Checked score
A figure from 0 to 100: the higher it is, the smaller the chance that the company goes bankrupt within twelve months. The band, from Critical to Excellent, follows from that chance; within the band, how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
Bankruptcy probability
The chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. 0.2% means about 2 in 1,000 comparable companies. The higher it is, the shorter the payment term to agree.
0.3%Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Sector median 0.2% (12,652 companies, NACE 82, micro)